al Pha rm inic Cl
aceutic arm s ph
y&B olog io ac
ISSN: 2167-065X
Clinical Pharmacology & Biopharmaceutics
Research Article
Trivedi et al., Clin Pharmacol Biopharm 2015, 4:2 http://dx.doi.org/10.4172/2167-065X.1000138
Open Access
Evaluation of the Impact of Biofield Treatment on Physical and Thermal Properties of Casein Enzyme Hydrolysate and Casein Yeast Peptone Trivedi MK, Nayak G, Patil S*, Tallapragada RM, Jana S and Mishra R Trivedi Global Inc., 10624 S Eastern Avenue Suite A-969, Henderson, NV 89052, USA
Abstract In the present study, the influence of biofield treatment on physical and thermal properties of Casein Enzyme Hydrolysate (CEH) and Casein Yeast Peptone (CYP) were investigated. The control and treated samples were characterized by Fourier transform infrared (FT-IR) spectroscopy, differential scanning calorimetry (DSC), Thermo Gravimetric Analysis (TGA), particle size and surface area analysis. The FTIR results revealed that biofield treatment has caused reduction of amide group (amide-I and amide-II) stretching vibration peak that is associated with strong intermolecular hydrogen bonding in treated CEH as compared to control. However, no significant changes were observed in FTIR spectrum of treated CYP. The TGA analysis of treated CEH showed a substantial improvement in thermal stability which was confirmed by increase in maximum thermal decomposition temperature (217°C) as compared to control (209°C). Similarly, the treated CYP also showed enhanced thermal stability as compared to control. DSC showed increase in melting temperature of treated CYP as compared to control. However the melting peak was absent in DSC of treated CEH which was probably due to rigid chain of the protein. The surface area of treated CEH was increased by 83% as compared to control. However, a decrease (7.3%) in surface area was observed in treated CYP. The particle size analysis of treated CEH showed a significant increase in average particle size (d50) and d99 value (maximum particle size below which 99% of particles are present) as compared to control sample. Similarly, the treated CYP also showed a substantial increase in d50 and d99 values which was probably due to the agglomeration of the particles which led to formation of bigger microparticles. The result showed that the biofield treated CEH and CYP could be used as a matrix for pharmaceutical applications.
Keywords: Casein enzyme hydrolysate; Casein yeast peptone; Biofield treatment; FT-IR; TGA; DSC; Particle size and Surface area
Abbreviations: CEH: Casein Enzyme Hydrolysate; CYP: Casein
Yeast Peptone; FT-IR: Fourier Transform Infrared Spectroscopy; TGA: Thermogravimetric Analysis; DSC: Differential Scanning Calorimetry; DTG: Derivative Thermogravimetry BET: Brunauer-Emmett-Teller; DDS: Drug Delivery Systems.
Introduction Over the last few decades, there has been continuous interest in biodegradable polymers for pharmaceutical and biomaterial applications [1]. Biodegradable polymers can be either synthetic or natural polymers. The synthetic polymers are more popular than their natural counterparts due to their excellent mechanical properties which can be used for biomedical applications. However the synthetic polymers are associated with toxicity problems which may cause problems during their intended medical use. Natural polymers are generally regarded as safe compared to synthetic polymers. Hence the natural polymers have clear advantages as drug delivery systems (DDS) [2]. Recently, protein based therapeutics, due to their excellent properties such as emulsification, foaming, gelling, and water holding ability have gained significant attention as DDS [3-6]. Moreover, the food proteins have their inherent ability to interact with wide range of bioactive compounds via functional groups present on their polypeptide structure. Hence, this offers the reversible binding of active molecules and protects them until their safe release in the human body [7,8]. Additionally, proteins are metabolizable; hydrolysis of the proteins by digestive enzymes releases the bioactive peptides that may cause a number of beneficial effects such as cardiovascular, endocrine, immune and nervous system [9,10]. Milk proteins are natural vehicles and widely explored in food industries due to their inherent nutritional and functional properties. Clin Pharmacol Biopharm ISSN: 2167-065X CPB, an open access journal
Casein is a main structural component of milk, where it accounts for 80% of total proteins content. Casein has been utilized in the production of food, pharmaceutical formulations and cosmetics. The interesting structure and physicochemical properties allows it to be used in DDS [11]. The casein has fascinating properties such as binding of ions and small molecules, excellent emulsification, surface active, gelation and water binding capacities. Hydrolysation of protein makes changes in the composition of potential groups; hydrophobic properties and functional characteristics [12]. For example CEH is a protein that is rapidly absorbed and digested similar to whey protein. Enzyme hydrolysis was recently used to modify the protein structure in order to enhance the functional properties of proteins. However, these chemical and enzymatic treatments might induce denaturation of protein which directly affects its functional properties. Bioelectromagnetism is an area which studies the interaction of living biological cells and electromagnetic fields. Researchers have demonstrated that short lived electrical current or action potential exists in several mammalian cells such as neurons, endocrine cells and muscle cells as well as some plant cells. An Italian physicist Luigi
*Corresponding author: Shrikant Patil, Trivedi Global Inc., 10624 S Eastern Avenue Suite A-969, Henderson, NV 89052, USA, Tel: +1 602-531-5400; E-mail: publication@trivedieffect.com Received June 10, 2015; Accepted June 29, 2015; Published July 06, 2015 Citation: Trivedi MK, Nayak G, Patil S, Tallapragada RM, Jana S, et al (2015) Evaluation of the Impact of Biofield Treatment on Physical and Thermal Properties of Casein Enzyme Hydrolysate and Casein Yeast Peptone. Clin Pharmacol Biopharm 4: 138. doi:10.4172/2167-065X.1000138 Copyright: © 2015 Trivedi MK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Volume 4 • Issue 2 • 1000138